Allovir Inc (NASDAQ:ALVR)
| 2.36 Delayed Data As of Dec 08 |  +0.06 / +2.61%Today’s Change | 1.31 Today|||52-Week Range 7.36 | -54.00% Year-to-Date |
Latest ALVR News | Press Releases
No recent news for Allovir Inc.
Today’s Trading
| Previous close | 2.30 |
| Today’s open | 2.28 |
| Day’s range | 2.24 - 2.39 |
| Volume | 79,046 |
| Average volume (3 months) | 861,778 |
| Market cap | $224.7M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +19.65% |
| Earnings growth (this year) | +18.10% |
| Earnings growth (next 5 years) | -89.33% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.82 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 8, 2024 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$168.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
